Pluri CEO Issues Letter to Shareholders Summarizing the Strategy Change and Progress in 2022 and Announcing Food Tech Joint Venture Proof of Concept

December 22, 2022

https://www.globenewswire.com/news-release/2022/12/22/2578488/11974/en/Pluri-CEO-Issues-Letter-to-Shareholders-Summarizing-the-Strategy-Change-and-Progress-in-2022-and-Announcing-Food-Tech-Joint-Venture-Proof-of-Concept.html

HAIFA, Israel, Dec. 22, 2022 (GLOBE NEWSWIRE) — Pluri Inc. (Nasdaq:PLUR) (TASE: PLUR) (“Pluri” or the “Company”) (formerly known as Pluristem Therapeutics, Inc.), a leading biotechnology Company, today issued the following update to shareholders from CEO and President Yaky Yanay and announced that as planned the Company’s joint venture with Tnuva Group has successfully achieved proof of concept in its development of cultivated meat based on Pluri’s proprietary 3D cell-based technology platform.

Read more at globenewswire.com

Related news for (PLUR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.